Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an intergroup rhabdomyosarcoma study
- 15 September 1995
- Vol. 76 (6), 1073-1085
- https://doi.org/10.1002/1097-0142(19950915)76:6<1073::aid-cncr2820760624>3.0.co;2-l
Abstract
There is a need to develop a single prognostically significant classification of rhabdomyosarcomas (RMS) and other related tumors of children, adolescents, and young adults which would be a current guide for their diagnosis, allow valid comparison of outcomes between protocols carried out anywhere in the world, and should enhance recognition of prognostic subsets. Sixteen pathologists from eight pathology groups, representing six countries and several cooperative groups, classified by four histopathologic classification schemes 800 representative tumors of the 999 eligible cases treated on Intergroup Rhabdomyosarcoma Study II. Each tumor was classified according to each of the four systems by each of the pathologists. In addition, two independent subsamples of 200 of the 800 patients were reviewed according to the new system, so that 343 distinct patients were reviewed once, and 57 of these twice. A study of the survival rates of all subtypes in the sample of 800 patients led to the formation of a new system. This was tested on two independent subsets of 200 of the original cases and found to be reproducible and predictive of outcome by univariate analysis. A multivariate analysis of the 343 patients classified according to the new system indicated that a survival model including pathologic classification and known prognostic factors of primary site, clinical group, and tumor size was significantly better at predicting survival than a model with only the known prognostic factors. This new classification, termed International Classification of Rhabdomyosarcoma (ICR) by the authors, was reproducible and predictive of outcome among patients with differing histologies treated uniformly on the Intergroup Rhabdomyosarcoma II protocols. We believe it should be utilized by all pathologists and cooperative groups to classify rhabdomyosarcomas in order to provide comparability among and within multi-institutional studies.Keywords
This publication has 25 references indexed in Scilit:
- Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas. Report of an international study of four pathology classificationsCancer, 1994
- Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcomaNature Genetics, 1993
- Childhood Rhabdomyosarocoma with Anaplastic (Pleomorphic) FeaturesThe American Journal of Surgical Pathology, 1993
- Relaxation of imprinted genes in human cancerNature, 1993
- Alveolar rhabdomyosarcoma with the t(2;13): Cytogenetic findings and clinicopathologic correlationsMedical and Pediatric Oncology, 1993
- Spindle Cell RhabdomyosarcomaThe American Journal of Surgical Pathology, 1992
- The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 casesHistopathology, 1990
- N‐myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMSInternational Journal of Cancer, 1990
- Histopathological classification of childhood rhabdomyosarcoma: A report from the international society of pediatric oncology pathology panelMedical and Pediatric Oncology, 1989
- Mortality among children with rhabdomyosarcomas of the alveolar histologic subtypeJournal of Pediatric Surgery, 1983